Frontpage has developed and facilitated external communication for Genomic Expression. With focus on targeting investor relations and capital increase through e.g. investor website, animations, social media strategy.
Genomic Expression has developed a pioneering RNA-analysis technology primarily used in diagnostics that help doctors determine, which medication is best for any given patient.
Genomic Expression’s research and development area is so specialised that it requires special information for investors – not just technically but also financially. Frontpage produced an investor website behind a login function. This gave Genomic Expression control of who accessed the information. FrontPage also produced a website with animation of the technology, LinkedIn page as a part of the branding strategy and business communication. Finally, Frontpage handled the ongoing investor relations communication.